⟵ Back to Search Results
BGB-11417-203

Recruiting

Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenström’s Macroglobulinemia

Beigene Study ID info

BGB-11417-203

ClinicalTrials.gov ID info

NCT05952037

EudraCT Number info

2023-503235-18

China Drug Trials ID info

CTR20232718

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years / N/A

No Study Documents